Global

Which is more compelling pick right now? – Sibanye Gold Limited (SBGL), OncoSec Medical Incorporated (ONCS)

The shares of Sibanye Gold Limited have decreased by more than -13.86% this year alone. The shares recently went up by 7.41% or $0.3 and now trades at $4.35. The shares of OncoSec Medical Incorporated (NASDAQ:ONCS), has jumped by 8.31% year to date as of 02/12/2018. The shares currently trade at $1.76 and have been able to report a change of 0.00% over the past one week.

The stock of Sibanye Gold Limited and OncoSec Medical Incorporated were two of the most active stocks on Monday. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? We will analyze the growth, profitability, risk, valuation, and insider trends of both companies and see which one investors prefer.

Profitability and Returns

Growth alone cannot be used to see if the company will be valuable. Shareholders will be the losers if a company invest in ventures that aren’t profitable enough to support upbeat growth. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure. SBGL has an EBITDA margin of 14.65%, this implies that the underlying business of SBGL is more profitable. These figures suggest that SBGL ventures generate a higher ROI than that of ONCS.



Liquidity and Financial Risk

The ability of a company to meet up with its short-term obligations and be able to clear its longer-term debts is measured using Liquidity and leverage ratios. The current ratio for SBGL is 1.00 and that of ONCS is 4.00. This implies that it is easier for SBGL to cover its immediate obligations over the next 12 months than ONCS. The debt ratio of SBGL is 1.24 compared to 0.00 for ONCS. SBGL can be able to settle its long-term debts and thus is a lower financial risk than ONCS.

Valuation




SBGL currently trades at a forward P/E of 5.88, a P/B of 0.83, and a P/S of 0.78 while ONCS trades at a P/B of 2.89, This means that looking at the earnings, book values and sales basis, SBGL is the cheaper one. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.

Analyst Price Targets and Opinions

The mistake some people make is that they think a cheap stock has more value to it. In order to know the value of a stock, there is need to compare its current price to its likely trading price in the future. The price of SBGL is currently at a -29.27% to its one-year price target of 6.15. Looking at its rival pricing, ONCS is at a -66.98% relative to its price target of 5.33. This figure implies that over the next one year, ONCS is a better investment.

When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), SBGL is given a 3.00 while 2.00 placed for ONCS. This means that analysts are more bullish on the outlook for SBGL stocks.

Insider Activity and Investor Sentiment

Short interest or otherwise called the percentage of a stock’s tradable shares currently being shorted is another data that investors use to get a handle on sentiment. The short ratio for SBGL is 5.02 while that of ONCS is just 1.80. This means that analysts are more bullish on the forecast for ONCS stock.

Conclusion

The stock of Sibanye Gold Limited defeats that of OncoSec Medical Incorporated when the two are compared, with SBGL taking 6 out of the total factors that were been considered. SBGL happens to be more profitable, generates a higher ROI, has higher cash flow per share, higher liquidity and has a lower financial risk. When looking at the stock valuation, SBGL is the cheaper one on an earnings, book value and sales basis. Finally, the sentiment signal for SBGL is better on when it is viewed on short interest.

Previous ArticleNext Article

Related Post

The Long Case For Zynerba Pharmaceuticals, Inc. (Z... Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) is in the highlights and many would want to know whether now might be a good time for it to present much u...
Are These Stocks A Sure Bet? – Keryx Biophar... The shares of Keryx Biopharmaceuticals, Inc. have decreased by more than -13.12% this year alone. The shares recently went down by -4.27% or -$0.18 an...
Does Teva Pharmaceutical Industries Limited (TEVA)... Teva Pharmaceutical Industries Limited (NYSE:TEVA)'s interesting series of developments are underway around the US stock market these days. Now tradin...
Understanding Technical Signals From Yamana Gold I... Yamana Gold Inc. (NYSE:AUY) fell by -2.17% in Tuesday’s trading session from $2.76 to $2.70 The stock price went upward in 6 of the last 10 days and h...
Which of 2 stocks would appeal to long-term invest... The shares of INSYS Therapeutics, Inc. have decreased by more than -27.28% this year alone. The shares recently went up by 7.90% or $0.49 and now trad...